The Vioxx debacle revisited

Am J Med. 2005 Sep;118(9):1058. doi: 10.1016/j.amjmed.2005.06.045.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Cyclooxygenase Inhibitors / adverse effects*
  • Drug Approval*
  • Humans
  • Lactones / adverse effects*
  • Product Surveillance, Postmarketing*
  • Risk Assessment
  • Sulfones / adverse effects*
  • United States
  • United States Food and Drug Administration*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib